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Abstract: Drug target identification is of significant commercial interest to pharmaceutical companies, and there is a vast amount of 
research done related to the topic of therapeutic target identification. Interdisciplinary research in this area involves both the  biological 
network community and the graph algorithms community. Key steps of a typical therapeutic target identification problem include 
synthesizing or inferring the complex network of interactions relevant to the disease, connecting this network to the disease-specific 
behavior, and predicting which components are key mediators of the behavior. All of these steps involve graph theoretical or graph 
algorithmic aspects. In this perspective, we provide modelling and algorithmic perspectives for therapeutic target identification and 
highlight a number of algorithmic advances, which have gotten relatively little attention so far, with the hope of strengthening the ties 
between these two research communities.
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Introduction
We begin with a motivating example to illustrate 
a typical therapeutic target design issue that is of 
interest to this paper. The blood cancer T-cell large 
granular lymphocyte (T-LGL) leukemia exhibits an 
abnormal proliferation of mature cytotoxic T lympho-
cytes (CTLs). CTLs are generated to eliminate cells 
infected by a virus, but unlike normal CTLs, which 
undergo activation-induced cell death after they suc-
cessfully fight the virus, leukemic T-LGL cells remain 
long-term competent.1 To date, 33 proteins and small 
molecules related to cytotoxic T lymphocyte acti-
vation and activation-induced cell death have been 
shown to be deregulated (eg, constitutively active) in 
T-LGL. It is known that prosurvival signalling path-
ways such as the MAPK and JAK-STAT3 pathways 
are upregulated and that T-LGL cells are insensitive 
to Fas-induced apoptosis (programmed cell death).2 
As there is no known curative therapy for T-LGL leu-
kemia, identification of a potential therapeutic target, 
for example, a protein whose knockdown would lead 
to apoptosis of these T-LGL cells, is of high priority.
The above example highlights some key steps of 
our typical therapeutic target identification problem, 
namely, we need to synthesize or infer the complex 
network of interactions relevant to the disease (in 
this case, the signalling network corresponding to 
activation-induced cell death), we need to connect 
this network to the relevant behavior (in this case, 
aberrant survival), and we need to predict which 
components are key mediators of the behavior. All 
of these steps involve nontrivial graph algorithmic 
aspects. In this review, we aim to highlight a number 
of algorithmic advances that have gotten relatively 
little attention so far.
Models of Interactions
We assume that the reader is familiar with basic graph 
algorithmic concepts3 as well as standard biological 
terminology in bioinformatics.4 We begin by recall-
ing two frequently used network representations for 
interacting biological systems.
Boolean model
The Boolean model is typically used in the context of 
studying dynamics of biological networks in which 
the measurement of quantities of interest (eg, gene 
expression levels) is binarized (eg, the expression 
level is either 1 or 0 indicating if the gene is expressed 
or not) or relative (eg, the expression level in con-
dition one is higher than that in condition two). The 
state and input variables are Boolean variables, and 
the function that updates the state of a variable is also 
a Boolean function (of other variables). Figure 1 pro-
vides a pictorial illustration of a Boolean model.
Regulatory network model
Formally, we define a regulatory network to be an 
edge-labelled directed graph in which nodes represent 
individual components of the biological system and 
directed edges of the form (u,v) indicates that node u 
has an influence on node v. The edge label (u,v) of an 
edge (u,v) indicates the nature of the causal relation-
ship, with (u,v) = 1 and (u,v) = −1 indicating that u 
has an excitatory (positive) and inhibitory (negative) 
influence on v, respectively (see Fig. 2). This rep-
resentation applies to gene regulatory networks 
(describing the regulation of gene transcription and 
related processes) and signal transduction networks 
(describing the information flow from external sig-
nals to within-cell components).
synthesizing signal Transduction 
networks
Signal transduction and gene regulatory networks 
are crucial to the maintenance of cellular homeosta-
sis and for cell behavior such as growth, survival, 
apoptosis, and movement. Deregulation of these 
networks is a key contributor to many disease pro-
cesses such as developmental disorders,5 diabetes,6 
vascular diseases,5,7 autoimmunity,8 and cancer.5,9,10 
For example, gene mutations or expression changes 
can lead to incorrect behaviors that result in tumour 
development and/or the promotion of cell migration 
and  metastasis.11 Thus identification of the  regulatory 
x1
x1(t+1) = ¬ x4(t)
x4(t+1) = x3(t)
x2(t+1) = x2(t) V x1(t)
x3(t+1) = x3(t) V (x2(t) ^ ¬ x4(t))
x2 x4
x3
Figure 1. A Boolean model with 4 state variables.
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networks responsible for cellular behaviors relevant 
to a certain disease is a crucial first step toward the 
development of therapeutic strategies targeting that 
disease. A key feature of this network is that it should 
contain a node (or a small set of nodes) that can be 
designated as a proxy or proxies for the disease. This 
node may be a concept node describing a behavior 
such as apoptosis or migration, and its upstream 
nodes (regulators) should be the proteins most directly 
responsible for the behavior, for example, caspases 
involved in programmed cell death. In the case of 
the T-LGL network, wherein apoptosis is the normal 
outcome, the best proxy for the disease should be a 
node that embodies the logical negation of  apoptosis. 
Its upstream regulators are the same nodes as the 
upstream regulators of the node apoptosis, but the 
sign (label) of the edges is reversed.
The synthesis of such a network starts with exten-
sively collecting the relevant literature and experi-
mental data concerning the interactions among the 
elements of the network. Although for many biologi-
cal processes different experiments generate an abun-
dance of relevant components and causal interactions, 
there is insufficient information on the overall struc-
ture and mechanisms of these processes. Therefore, 
information sources from individual experiments 
need to be assembled and integrated.
Experimental evidence about the involvement of 
a component or a regulatory relationship in a bio-
logical process has several types. For example, a 
concentration change of a protein after treating the 
system with an input signal indicates that this protein 
may be a component of this signal’s signal transduc-
tion network. Such evidences can be collected from 
high-throughput gene expression, proteomics, and 
metabolomics data. In addition, if knocking out or 
overexpressing a component leads to a change in the 
relevant cellular response, it can be concluded that 
this component is involved in the biological process. 
Causal relationships between components can be col-
lected from high-throughput phospho-proteomics, 
protein-DNA interaction, as well as genetic interac-
tion studies. These causal relationships can be rep-
resented as directed edges from one component to 
another characterized by one of two signs: activating 
(positive) or inhibitory (negative). However, in some 
cases, perturbation experiments lead to composite 
causal relationships, which need to be broken down 
to component-to-component relationships depending 
on the concrete situation. In all but a handful of well-
studied cases, a very useful step in network analysis 
is to find the most parsimonious (minimal) network 
that explains all the experimentally obtained causal 
observations.
The generation of this most parsimonious network 
from an initially too-redundant network involves sys-
tematically removing those edges or nodes that do not 
change “appropriate” reachability relations between 
nodes. For this purpose, we start by describing two 
necessary network optimization problems.
Binary transitive reduction and 
pseudo node collapse
For these two problems, the notation u ⇒xv is used 
to denote a (directed) path P from u to v of parity 
x = Πe∈P (e) ∈{−1,1} (an edge is simply denoted by 
u →xv).
The first optimization problem is the binary tran-
sitive reduction (BTR) problem.12–14 In this prob-
lem, our goal is to find a minimal subgraph from the 
original nonminimal signal transduction network by 
removing the “redundant” edges, namely those edges 
u→xv for which an alternate pathway u ⇒xv not using 
the edge u →xv exists. See Figure 3 for an illustration. 
The goal of BTR is to produce a network topology 
that is as close as possible to a tree  topology while 
supporting all experimental observations. The implicit 
 assumption of tree-like topologies permeates the tra-
ditional molecular biology literature: signal trans-
duction and metabolic pathways were assumed to 
be close to linear chains, and genes were assumed 
to be regulated by one or two transcription factors.15 
x1
−1 −1
−1
−1
1
1 x4
x3x2
Figure 2. A signal transduction network.
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Figure 3. An illustration of BTR.
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Interaction with biologists
(1) [Encoding direct interactions]
(2) [Encoding double causal interactions]
Biochemical and pharmacological evidences that define component-to-
compontent relationships, namely of the form “A promotes B” or “A in-
hibits B”, are incorporated (in arbitrary order) as directed edges A→1B or
A→−1B, respectively. If the interaction is known to be a direct interac-
tion with concrete evidence, then the edge is marked as a critical edge and
included in Ec. 
Consider each double causal interaction A→x (B→y C), where x,y ∈{−1, 1}, in an arbitrary order. Add new nodes and/or edges in the net-
work based on the following cases:
• If B →y C ∈Ec, then add the edge A→xB.
A
A
B
B P
a
a
b
x
b
x
D C
C
• Otherwise, if there is no subgraph (in the network constructed so far) of
   the form
(2)(1)
Optimize
(BTR, PVC)
for some node D where b = ab = y, then add
to the network where P is a new pseudo-the subgraph
node and b = a b = y.
Figure 4. A framework for network synthesis using BTR and PNC.16–18,23
According to current observations, the reality is not 
far: the average in/out degree of transcriptional regu-
latory networks16,17 and the mammalian signal trans-
duction network18 is close to 1.
The second optimization problem is the (generalized) 
pseudo-node-collapse (PNC) problem.13,14 An instance 
of PNC includes a given subset V
pseudo
 ⊆ V of nodes called 
pseudo nodes. For any node v, define in(v) = {(u,x) | u 
⇒xv}\{v} and out(v) = {(u,x) | v ⇒x u}\{v}. Collapsing 
2 nodes u and v is permissible provided at least one of 
them is a pseudo node, in(u) = in(v) and out(u) = out(v). 
If permissible, the collapse of 2 nodes u and v cre-
ates a new vertex w, makes every incoming (respec-
tively, outgoing) edge to (respectively from) either u 
or v an incoming (respectively, outgoing) edge from w, 
removes any parallel edge that may result from the col-
lapse operation, and also removes both nodes u and v. 
Our goal is to obtain a minimal graph G’ = (V’,E’) 
from G by a sequence of permissible collapse opera-
tions such that G’ is consistent, that is, for no pairs of 
nodes u and v both u ⇒1v and u ⇒−1v exists.
network construction
Following the approaches in Kachalo et al,13 Albert 
et al,14 and Albert et al,19 interaction information 
between components can be partitioned into two main 
categories: (1) Direct interactions related to biochemi-
cal evidences that provide information on enzymatic 
activity or protein-protein interactions. (2) Putative 
interaction patterns (double-causal relationships) that 
arise from the observation of differential responses 
following perturbation experiments. For example, a 
decreased response (R) to a stimulus (S) in an organ-
ism wherein component X was knocked out, as com-
pared to the normal (wild-type) organism, leads to the 
double-causal relationship X ⇒x (S ⇒y R).
Kachalo et al,13 Albert et al,14 and Albert et al19 
describe a general methodology for synthesizing 
direct and double-causal information into a minimal 
consistent network. The methodology is shown in 
Figure 4. A software named NET-SYNTHESIS for 
synthesis of networks based on the framework in 
 Figure 4 was reported in Kachalo et al13 and Albert 
et al;19 this software was used to build a network model 
to study the signalling components that effect the sur-
vival of cytoxic T lymphocytes in LGL Leukemia.20
Pathway preserving network 
simplification
PNC can also be used in a much broader context of 
network simplification in the following manner. In 
many large-scale regulatory networks, only a subset of 
the nodes are of inherent interest (eg, because they are 
differentially expressed in different exogenous condi-
tions), and the rest serve as background or mediators. 
One can therefore designate nodes of less interest or 
confidence as pseudo nodes and then collapse them, 
thereby making the network among high-interest/con-
fidence nodes easier to interpret. For example, using 
this approach, PNC with BTR can be used to focus on 
specific pathways in disease networks to better under-
stand the molecular mechanism of the onset of the dis-
ease and therefore help in drug target identification.13
Network modeling in therapeutic target prediction
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As an illustration, this approach was used by 
 Kachalo et al13 to focus on pathways that involve 
the 33 known T-LGL deregulated proteins in a 
 cell-survival/cell-death regulation related signalling 
network  synthesized from the Transpath 6.0 database.
The approach used by Kachalo et al was to focus 
special interest on the effect of Ras on apoptosis 
response through Fas/FasL pathway by designating 
nodes that correspond to proteins with no evidence 
of being changed during this effect as pseudo nodes 
and simplifying the network via iterations of PNC 
and BTR. Although performing comprehensive PNC 
in this manner may lead to a drastic reduction of the 
network, the drawback of such a dramatic simplifica-
tion is that pairs of incoherent edges (two edges with 
opposite labels) can appear among the same pair of 
nodes. While incoherent paths between pairs of nodes 
are often seen in biological regulatory networks, 
interpretation of incoherent edges is difficult without 
knowledge of the mediators of the two opposite regu-
latory mechanisms. Thus, optimal simplification in 
this manner may require careful selection of pseudo 
nodes and PNC algorithms.
Therapeutic Target Identification
Many approaches to therapeutic target identification 
are based on analysis of molecular interaction net-
works. Certain approaches are based on genome-wide 
reconstructed networks; others aim to first construct 
the network most relevant to the disease. A powerful 
view of the first type is that tumor cell types are attrac-
tors of the global gene regulatory network.21 These 
attractors are normally inaccessible (ie, normal cell 
processes will not lead to tumor development), but 
genetic mutations can distort the attractor basins in 
such a way that a previously nonaccessible attractor 
is now accessible. The therapeutic target identifica-
tion then involves finding the perturbations that make 
the malignant cells revert to the trajectory that leads 
to the nonmalignant, more differentiated cell.
Approaches of the second type focus on known dis-
ease-associated networks, such as growth factor sig-
naling networks, which are frequently deregulated in 
cancer. Layek et al22 constructed a Boolean represen-
tation of a signaling network that contains five growth 
factors as inputs and seven proliferative and anti-
apoptotic proteins as outputs. Based on this network, 
they determined the node faults (eg, stuck-at-zero, 
stuck-at-one) that change the output nodes’ states. 
They also identified the combinations of existing 
drugs that would best mitigate each fault.
A powerful way of identifying therapeutic targets 
is to identify the nodes most essential for mediat-
ing the abnormal outcome. For this application, the 
reconstructed signal transduction network relevant to 
a disease contains an output node that is a proxy for 
the disease. In graph theoretical terms, essentiality for 
mediating the abnormal outcome can be expressed as 
high centrality in the input-output network. A mul-
titude of node centrality measure exists, and several 
of them, such as closeness centrality,23 were fruitfully 
used to predict key nodes in biological regulatory 
networks. A deeper, dynamic analysis by Abdi et al24 
adapted methods of circuit fault diagnosis engineering 
to signaling networks to determine the vulnerability 
of the network to the dysfunction of each node. The 
nodes with highest vulnerability value were identi-
fied as key nodes. One such prediction was validated 
experimentally. The method proposed by Wang and 
Albert25 bridges graph-based and Boolean analysis by 
developing an enriched graph representation, which 
we describe next.
Network expansion
The starting point is to describe each node v by a dis-
junctive normal Boolean rule
 
v u       u
 u      u
   
 
= ∧ ∧( )
∨ ∧ ∧( )
∨ ∨
 1,1  ,n
2,1 2,n
 m,1
1
2
u



1
 
 ∧ ∧( )     u m,nm
where the ui,j s are regulators of node v. The opera-
tors connecting the regulators are decided from the 
literature. In the absence of evidence for conditional 
dependence (the necessity of two regulators to work 
together to be effective), the default representation of 
multiple activating edges converging on the same node 
is an OR () relationship. Information on conditional 
dependence is incorporated by AND () relationships 
among edges. Inhibitory regulations are represented by 
the logical operator NOT. If an inhibitory regulation is 
dominant among multiple interactions, as is often the 
case, AND NOT should be used; otherwise one can use 
OR NOT, which means that the absence of an inhibitor 
is similar to the presence of an activator.
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To incorporate inhibitory interactions, a 
 complementary node is introduced for each node, or 
at a minimum for each node that negatively  regulates 
other nodes or is being negatively  regulated by other 
nodes. This complementary node represents the 
 logical negation of the original node, and its Boolean 
rule is thus the negation of the original node’s rule. 
Correspondingly, an inhibitory edge starting at 
a node becomes an activating edge  starting at its 
 complementary node. An inhibitory edge ending 
at a node becomes an activating edge ending at its 
 complementary node. For each set of conditional 
interactions (with AND relationship) ending at a 
node, a composite node is introduced. The regula-
tors of v activate the composite node, which then 
 activates the node v.
Introducing complementary nodes and composite 
nodes increases the number of nodes and edges in the 
network, but the benefit is that ambiguity is  eliminated. 
All the directed interactions in the expanded network 
represent activation. All edges ending at a  composite 
node are conditionally dependent on each other, 
and multiple edges ending in an original node or 
 complementary node are independent.
input-output connectivity
Elementary flux modes, that is, minimal sets of 
enzymes that can make metabolic systems operate 
at steady states, play an important role in metabolic 
network analysis.23 Analogously, an elementary sig-
nalling mode (ESM) can be defined as a minimal set 
of components that can perform signal transduction 
from initial signals to cellular responses. By minimal, 
we mean that an ESM is not decomposable and none 
of its signalling components is redundant, that is, 
knockout of any of the nodes in the ESM will make it 
unable to transducer the signal. The concept of ESM 
is an extension of the graph concept of simple path. 
An ESM that does not contain any composite nodes 
is indeed a simple path. If the ESM has a composite 
node, it additionally includes all the edges ending at 
the composite node and their source nodes.
ESM identification was implemented in three dif-
ferent ways25–27: using an extension of depth-first 
search (most useful for acyclic networks), an iterative 
integer linear programming algorithm (most useful 
for small networks), and a subgraph-growing bottom-
up algorithm.
Node essentiality
The main idea is to rank the importance of signalling 
components by the effects of their perturbation on the 
ESMs of the network. It is important to realize that the 
disruption of any single node may lead to a cascading 
breakdown of a large part of the system as nodes that 
lost their indispensable regulators will be lost as well. 
There are three cases for a regulator v to be indispens-
able for a direct target node u: if v is the sole regulator 
of u, if u is a composite node, or if v is the only remain-
ing regulator of u left due to the disruption of other 
 regulators. The cascading effect of the removal of a 
node can be determined by an algorithm that iteratively 
finds and deletes the nodes that have just lost their indis-
pensable regulators. Each node v is then characterized 
by the relative reduction in the number of ESMs due to 
the removal of v and its cascading effects.
Wang and Albert25 apply this method to various 
signalling networks20,28–30 and compare the essentiality 
values with the results of Boolean dynamic models. 
Components are classified as essential in the dynamic 
model if their elimination (OFF state) leads to incor-
rect dynamic behaviors, and nonessential otherwise. 
Components are classified as essential in the graph 
method if their importance value is above a threshold. 
They find high sensitivity (fraction of essential com-
ponents that are recognized by a method) coupled 
with high specificity (fraction of nonessential compo-
nents that are recognized by a method) for a range of 
thresholds for all the networks. Several specific nodes 
identified as highly essential are well-supported by 
experimental observations.25
In the specific example of the T-LGL network, 14 
components have importance values of one (or very 
close to one).31 This means that blocking any of these 
nodes disrupts (almost) all signalling paths from the 
complementary node to apoptosis, thus these nodes 
are candidate therapeutic targets. All of these nodes 
are also found to be essential for the T-LGL survival 
state according to a dynamic model, that is, reversing 
their states causes apoptosis to be the only possible 
outcome of the system. Moreover, experimental veri-
fication of the importance of these nodes exists for 10 
of the 14 nodes.31
conclusion
In this perspective, we have highlighted a few algorith-
mic advances related to therapeutic identification, which 
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have received relatively little attention so far. We believe 
that this very important research area will benefit a great 
deal from interdisciplinary investigations that identify 
the most fruitful abstractions and develop the compu-
tational methodologies most suitable for parsimonious 
predictive modelling, and we hope that this perspective 
will strengthen the ties between the biological network 
and graph algorithm research communities.
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